Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

989 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Role of 2-[18F]-fluorodeoxyglucose (FDG) positron emission tomography (PET) in the early assessment of response to chemotherapy in metastatic breast cancer patients.
Gennari A, Donati S, Salvadori B, Giorgetti A, Salvadori PA, Sorace O, Puccini G, Pisani P, Poli M, Dani D, Landucci E, Mariani G, Conte PF. Gennari A, et al. Among authors: mariani g. Clin Breast Cancer. 2000 Jul;1(2):156-61; discussion 162-3. doi: 10.3816/cbc.2000.n.014. Clin Breast Cancer. 2000. PMID: 11899654
Evaluation of Post-Surgical Non-Small Cell Lung Cancer by PET with FDG.
Mariani G, Chella A, Giorgetti A, Davini F, Bonora D, Sorace O, Poli M, Mussi A, Angeletti CA, Salvadori PA. Mariani G, et al. Clin Positron Imaging. 1999 Nov;2(6):343. doi: 10.1016/s1095-0397(99)00103-x. Clin Positron Imaging. 1999. PMID: 14516640 No abstract available.
Gleason score at diagnosis predicts the rate of detection of 18F-choline PET/CT performed when biochemical evidence indicates recurrence of prostate cancer: experience with 1,000 patients.
Cimitan M, Evangelista L, Hodolič M, Mariani G, Baseric T, Bodanza V, Saladini G, Volterrani D, Cervino AR, Gregianin M, Puccini G, Guidoccio F, Fettich J, Borsatti E. Cimitan M, et al. Among authors: mariani g. J Nucl Med. 2015 Feb;56(2):209-15. doi: 10.2967/jnumed.114.141887. Epub 2014 Dec 31. J Nucl Med. 2015. PMID: 25552670 Free article.
Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors: primary results of a phase IIIb, open-label, single-arm, expanded-access multicenter trial (BALLET).
Jerusalem G, Mariani G, Ciruelos EM, Martin M, Tjan-Heijnen VC, Neven P, Gavila JG, Michelotti A, Montemurro F, Generali D, Simoncini E, Lang I, Mardiak J, Naume B, Camozzi M, Lorizzo K, Bianchetti S, Conte P. Jerusalem G, et al. Among authors: mariani g. Ann Oncol. 2016 Sep;27(9):1719-25. doi: 10.1093/annonc/mdw249. Epub 2016 Jun 29. Ann Oncol. 2016. PMID: 27358383 Free article. Clinical Trial.
989 results